New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
scPharmaceuticals Inc.
SCPH
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

157M

Biotechnology

Next Earning date - 13 May 2025

157M

Biotechnology

Next Earning date - 13 May 2025

3.00USD

Shape-0.01 ( -0.33%)
moonAfter-hours 3.47$arrow-right-up0.00 (0.00%)
Market Closed (as of Mar 21, 20:00 EDT)
favorite-chart

Relative Strenght

19
favorite-chart

Volume Buzz

38%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

47%

Quote Panel

Shape
Updated March 24, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

SCPH

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$76M

Shape527%

2025-Revenue

$0.98

ShapeNaN%

2025-EPS

$15M

Shape188%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

SVB Leerink

upgrade

Previous: Not converted

2022-10-11

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.30
vs -0.28

Q2.23

arrow
arrow

N/A

-0.36
vs -0.35

Q3.23

arrow
arrow

N/A

-0.41
vs -0.37

Q4.23

arrow
arrow

N/A

-0.35
vs -0.30

Q1.24

arrow
arrow

N/A

-0.36
vs -0.30

Q2.24

arrow
arrow

N/A

-0.44
vs -0.36

Q3.24

arrow
arrow

N/A

-0.37
vs -0.41

Q4.24

arrow
arrow

N/A

-0.35
vs -0.35

Q1.25

arrow
arrow

N/A

-0.30
vs -0.36

Q2.25

arrow
arrow

N/A

-0.26
vs -0.44

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

NA

2.1M  vs NA

Q2.23

arrow
arrow

NA

1.6M  vs NA

Q3.23

arrow
arrow

NA

3.8M  vs NA

Q4.23

arrow
arrow

NA

6.1M  vs NA

Q1.24

arrow
arrow

+196%

6.1M  vs 2.1M

Q2.24

arrow
arrow

+392%

8.1M  vs 1.6M

Q3.24

arrow
arrow

+164%

10M  vs 3.8M

Q4.24

arrow
arrow

+99%

12.2M  vs 6.1M

Q1.25

arrow
arrow

+91%

11.6M  vs 6.1M

Q2.25

arrow
arrow

+104%

16.4M  vs 8.1M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+5%

0.05
vs 0.04

Q2.23

arrow
arrow

+6%

0.06
vs 0.05

Q3.23

arrow
arrow

-32%

-0.32
vs 0.06

Q4.23

arrow
arrow

-37%

-0.37
vs -0.32

Q1.24

arrow
arrow

-57%

-0.57
vs -0.37

Q2.24

arrow
arrow

-185%

-1.85
vs -0.57

Q3.24

arrow
arrow

-114%

-1.14
vs -1.85

Q4.24

arrow
arrow

-141%

-1.41
vs -1.14

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

66

66
vs 62

6%

Q2.23

arrow
arrow

85

85
vs 66

29%

Q3.23

arrow
arrow

77

77
vs 85

-9%

Q4.23

arrow
arrow

85

85
vs 77

10%

Q1.24

arrow
arrow

81

81
vs 85

-5%

Q2.24

arrow
arrow

80

80
vs 81

-1%

Q3.24

arrow
arrow

98

98
vs 80

23%

Q4.24

arrow
arrow

87

87
vs 98

-11%

Earnings Growth

Latest News